Rochelle Demsky

1.3k total citations
25 papers, 686 citations indexed

About

Rochelle Demsky is a scholar working on Genetics, Oncology and Reproductive Medicine. According to data from OpenAlex, Rochelle Demsky has authored 25 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 9 papers in Oncology and 8 papers in Reproductive Medicine. Recurrent topics in Rochelle Demsky's work include BRCA gene mutations in cancer (22 papers), Ovarian cancer diagnosis and treatment (8 papers) and Prenatal Screening and Diagnostics (4 papers). Rochelle Demsky is often cited by papers focused on BRCA gene mutations in cancer (22 papers), Ovarian cancer diagnosis and treatment (8 papers) and Prenatal Screening and Diagnostics (4 papers). Rochelle Demsky collaborates with scholars based in Canada, United States and Poland. Rochelle Demsky's co-authors include Steven A. Narod, Barry P. Rosen, Susan Randall Armel, Kelly Metcalfe, Amy Finch, Joan Murphy, Esther M. John, Jeanna McCuaig, Joanne Kotsopoulos and Laurie Elit and has published in prestigious journals such as American Journal of Clinical Nutrition, Cancer Research and International Journal of Cancer.

In The Last Decade

Rochelle Demsky

24 papers receiving 665 citations

Peers

Rochelle Demsky
M. Daly United States
Faiza Gaba United Kingdom
Thea M. Mooij Netherlands
Deborah J. Goldfrank United States
Sue Friedman United States
Robin A. Lacour United States
SA Narod Canada
Rochelle Demsky
Citations per year, relative to Rochelle Demsky Rochelle Demsky (= 1×) peers Irène Feroce

Countries citing papers authored by Rochelle Demsky

Since Specialization
Citations

This map shows the geographic impact of Rochelle Demsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rochelle Demsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rochelle Demsky more than expected).

Fields of papers citing papers by Rochelle Demsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rochelle Demsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rochelle Demsky. The network helps show where Rochelle Demsky may publish in the future.

Co-authorship network of co-authors of Rochelle Demsky

This figure shows the co-authorship network connecting the top 25 collaborators of Rochelle Demsky. A scholar is included among the top collaborators of Rochelle Demsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rochelle Demsky. Rochelle Demsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metcalfe, Kelly, Andrea Eisen, Aletta Poll, et al.. (2021). Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result. Annals of Surgical Oncology. 28(9). 4967–4973. 12 indexed citations
2.
3.
Eisen, Andrea, Rochelle Demsky, Kristina M. Blackmore, et al.. (2019). Predictors of mammographic density among women with a strong family history of breast cancer. BMC Cancer. 19(1). 631–631. 9 indexed citations
4.
Kim, Shana J., Rochelle Demsky, Susan Randall Armel, et al.. (2019). Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case–control study. Breast Cancer Research and Treatment. 174(3). 741–748. 24 indexed citations
5.
Eisen, Andrea, Rochelle Demsky, Kristina M. Blackmore, et al.. (2018). Serum osteoprotegerin levels and mammographic density among high-risk women. Cancer Causes & Control. 29(6). 507–517. 6 indexed citations
6.
Stjepanovic, Neda, Michelle Wilson, Hal K. Berman, et al.. (2017). Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene. Cancer Research. 77(4_Supplement). P3–9. 2 indexed citations
7.
Kim, Shana J., Kyoung‐Jin Sohn, Jan Lubiński, et al.. (2016). Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study,. American Journal of Clinical Nutrition. 104(3). 671–677. 25 indexed citations
8.
Metcalfe, Kelly, Cindy‐Lee Dennis, Aletta Poll, et al.. (2016). Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genetics in Medicine. 19(3). 330–336. 37 indexed citations
9.
Kotsopoulos, Joanne, Tomasz Huzarski, Jacek Gronwald, et al.. (2016). Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study. Breast Cancer Research and Treatment. 155(2). 365–373. 49 indexed citations
10.
Fox, Edward, Jeanna McCuaig, Rochelle Demsky, et al.. (2015). The sooner the better: Genetic testing following ovarian cancer diagnosis. Gynecologic Oncology. 137(3). 423–429. 17 indexed citations
11.
Kotsopoulos, Joanne, Jan Lubiński, Susan L. Neuhausen, et al.. (2015). Weight Gain After Oophorectomy Among Women with a BRCA1 or BRCA2 Mutation. Women s Health. 11(4). 453–459. 2 indexed citations
12.
Armel, Susan Randall, Jeanna McCuaig, Rochelle Demsky, et al.. (2015). All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates. Journal of Genetic Counseling. 24(5). 822–832. 5 indexed citations
13.
Kotsopoulos, Joanne, Kelly Metcalfe, Ophira Ginsburg, et al.. (2014). Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’. BMC Cancer. 14(1). 221–221. 12 indexed citations
14.
Kotsopoulos, Joanne, Jan Lubiński, Jacek Gronwald, et al.. (2014). Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 137(5). 1136–1146. 48 indexed citations
15.
Demsky, Rochelle, Jeanna McCuaig, Manjula Maganti, et al.. (2013). Keeping it simple: Genetics referrals for all invasive serous ovarian cancers. Gynecologic Oncology. 130(2). 329–333. 35 indexed citations
16.
Demsky, Rochelle, et al.. (2013). Keeping It Simple. Obstetrical & Gynecological Survey. 68(10). 686–688. 1 indexed citations
17.
McCuaig, Jeanna, Susan Randall Armel, Ana Novokmet, et al.. (2012). Routine TP53 testing for breast cancer under age 30: ready for prime time?. Familial Cancer. 11(4). 607–613. 61 indexed citations
18.
Finch, Amy, Kelly Metcalfe, Laurie Elit, et al.. (2011). The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecologic Oncology. 121(1). 163–168. 154 indexed citations
19.
Finch, Amy, Kelly Metcalfe, Rochelle Demsky, et al.. (2009). Breast and ovarian cancer risk perception after prophylactic salpingo‐oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clinical Genetics. 75(3). 220–224. 17 indexed citations
20.
Metcalfe, Kelly, Aletta Poll, Annette M. O’Connor, et al.. (2007). Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 72(3). 208–217. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026